[
  {
    "ts": null,
    "headline": "Guggenheim Maintains AbbVie (ABBV) Buy Recommendation",
    "summary": "Guggenheim Maintains AbbVie (ABBV) Buy Recommendation",
    "url": "https://finnhub.io/api/news?id=0cdf6af0f901cd6a7cc4e2a8c5f6c243604ae5d6f82b9e00023b6fe1fb0a1187",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761000070,
      "headline": "Guggenheim Maintains AbbVie (ABBV) Buy Recommendation",
      "id": 137171000,
      "image": "",
      "related": "ABBV",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0cdf6af0f901cd6a7cc4e2a8c5f6c243604ae5d6f82b9e00023b6fe1fb0a1187"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=f8529fae02d5f0c32b278194dcca2abfafd4ec4506bdb365a1e7f404faea8548",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760977860,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 137225451,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f8529fae02d5f0c32b278194dcca2abfafd4ec4506bdb365a1e7f404faea8548"
    }
  },
  {
    "ts": null,
    "headline": "Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings",
    "summary": "ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's decline.",
    "url": "https://finnhub.io/api/news?id=1e9dbaf41953c277f26e4ff578a8861bfff09a0cdfb19eb428566cf3bedcc0c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760969400,
      "headline": "Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings",
      "id": 137174096,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's decline.",
      "url": "https://finnhub.io/api/news?id=1e9dbaf41953c277f26e4ff578a8861bfff09a0cdfb19eb428566cf3bedcc0c4"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For October",
    "summary": "Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.",
    "url": "https://finnhub.io/api/news?id=7e5e4d81e7f7bbf4ace2094dc8b479304205e7043756c5390b7cef95e12da826",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760955567,
      "headline": "IXJ: Healthcare Sector Dashboard For October",
      "id": 137167977,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409850701/image_1409850701.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.",
      "url": "https://finnhub.io/api/news?id=7e5e4d81e7f7bbf4ace2094dc8b479304205e7043756c5390b7cef95e12da826"
    }
  }
]